
A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5-fluorouracil (FEC100) followed by cisplatin–docetaxel with or without trastuzumab in locally advanced breast cancer
AL-Tweigeri, Taher, AlSayed, Adher, Alawadi, Shafika, Ibrahim, Mohamed, Ashour, Wafaa, Jaafar, Hassan, Abulkhair, Omalkhair, AL-Abdulkarim, Huda, Khalid, Hassan, Ajarim, DahishVolume:
77
Langue:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-015-2906-5
Date:
January, 2016
Fichier:
PDF, 626 KB
english, 2016